Company Filing History:
Years Active: 2007
Title: Christoffer Abrahamson: Innovator in Pharmaceutical Analysis
Introduction
Christoffer Abrahamson, based in Arlöv, Sweden, is a notable inventor recognized for his contributions to pharmaceutical analysis. His expertise lies in developing methods that enhance the analytical capabilities of pharmaceutical samples, which is crucial for ensuring the efficacy and safety of medications.
Latest Patents
Abrahamson holds a patent titled "Method of analysing a pharmaceutical sample." This innovative method revolves around determining the amount of free gas in a pharmaceutical sample. The process involves several steps: providing a sample before an irradiating source, irradiating the sample with electromagnetic radiation, detecting the emitted radiation, and correlating the resulting signals to solid-state parameters of the sample. This invention represents a significant stride in pharmaceutical research.
Career Highlights
Christoffer Abrahamson is associated with AstraZeneca AB, a global biopharmaceutical company that is at the forefront of developing innovative medicines. His work contributes to the company's mission, focusing on improving patient outcomes through advanced drug formulation and analysis.
Collaborations
Throughout his career, Abrahamson has collaborated with esteemed colleagues such as Stefan Andersson-Engels and Staffan Folestad. These collaborations have fostered an environment of innovation within the company, enabling the development of groundbreaking technologies in the pharmaceutical industry.
Conclusion
Christoffer Abrahamson exemplifies the spirit of innovation in the pharmaceutical field through his patented method for analyzing pharmaceutical samples. His work not only enhances the understanding of pharmaceutical compositions but also plays a vital role in ensuring the quality and safety of medications. With ongoing advancements and collaborations, Abrahamson continues to make a significant impact in the world of pharmaceutical research.